Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Pharmaceuticals: Major10
Biotechnology8
Medical Specialties2
Medical/Nursing Services2
Miscellaneous Commercial Services1
Investment Managers1
Chemicals: Agricultural1

Countries of related companies

United States15
Belgium4
Spain1
Sweden1
United Kingdom1
France1
Netherlands1
Switzerland1
Logo argenx SE
argenx SE is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx SE aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx SE developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises.
Employees
1,599
More about the company